1. Clinical Overview
Balofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic. It is a DNA gyrase inhibitor with enhanced activity against Gram-positive bacteria and atypical pathogens compared to earlier fluoroquinolones. It is particularly noted for its once-daily dosing, good tissue penetration, and a favorable safety profile with a lower incidence of phototoxicity and CNS effects. In India, it is primarily used for community-acquired respiratory and urinary tract infections.
| Onset | Duration | Bioavailability |
|---|---|---|
| Rapid absorption leads to peak plasma concentrations within 1-2 hours. | Approximately 24 hours, supporting once-daily dosing. | Approximately 80-90% after oral administration. |
2. Mechanism of Action
Balofloxacin is a bactericidal antibiotic. Its primary mechanism involves inhibition of two essential bacterial type II topoisomerase enzymes: DNA gyrase (primarily in Gram-negative bacteria) and topoisomerase IV (primarily in Gram-positive bacteria).
3. Indications & Uses
- Acute bacterial exacerbation of chronic bronchitis (AECB)
- Community-acquired pneumonia (CAP) of mild to moderate severity
- Uncomplicated urinary tract infections (UTIs) like cystitis
- Complicated urinary tract infections (cUTIs)
4. Dosage & Administration
Adult Dosage: 400 mg once daily. For mild to moderate infections, a 200mg once daily dose may be used as per physician discretion. Typically administered for 5-10 days depending on infection severity and site.
Administration: To be taken orally, with or without food. Should be swallowed whole with a full glass of water. Maintain adequate hydration. Do not take with dairy products, calcium-fortified juices, or antacids containing divalent/trivalent cations (Al, Mg, Ca, Fe, Zn) as they significantly reduce absorption. Maintain a minimum 2-hour gap.
5. Side Effects
Common side effects may include:
- Nausea
- Diarrhea
- Headache
- Dizziness
- Abdominal discomfort
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Antacids (Aluminum, Magnesium), Sucralfate, Multivitamins/Minerals (Iron, Zinc, Calcium) | Form chelation complexes, drastically reducing balofloxacin absorption. | Major |
| Didanosine (buffered formulation) | Contains aluminum/magnesium buffers; reduces absorption. | Major |
| Warfarin | May enhance anticoagulant effect, increasing INR and bleeding risk. | Major |
| NSAIDs (e.g., Ibuprofen, Aspirin) | May increase the risk of CNS stimulation and seizures. | Moderate |
| Oral Hypoglycemics (Sulfonylureas) / Insulin | May enhance hypoglycemic effect; monitor blood glucose. | Moderate |
| Corticosteroids (Systemic) | Increased risk of tendon rupture, especially in elderly. | Major |
| Other QT-prolonging drugs (e.g., Amiodarone, Sotalol, Macrolides, TCAs, Antipsychotics) | Additive risk of QT prolongation and cardiac arrhythmias. | Major |
| Probenecid | May reduce renal tubular secretion of balofloxacin, increasing its plasma levels. | Moderate |
7. Patient Counselling
- DO complete the full prescribed course, even if you feel better.
- DO take the tablet with a full glass of water and stay well-hydrated.
- DO inform your doctor about all other medicines, vitamins, or supplements you are taking.
- DO maintain at least a 2-hour gap between balofloxacin and antacids, dairy, or iron/calcium/zinc supplements.
- DONT skip doses.
- DONT take it with milk, yogurt, or calcium-fortified juice.
- DONT share your medicine with others.
8. Toxicology & Storage
Overdose: Symptoms may include nausea, vomiting, dizziness, headache, confusion, and seizures. Acute renal failure may occur with massive overdose.
Storage: Store below 30°C, in a cool, dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the pack.